24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
PEPTIDOMIMETIC CD40L BINDING |
84% |
|
ALZHEIMERS |
16% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
PEPTIDOMIMETIC CD40L BINDING |
44% |
|
ENZYME DYNAMICS |
28.34% |
|
CANCER |
16.57% |
|
ALZHEIMERS |
11.09% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
CANCER |
27.45% |
|
ENZYME DYNAMICS |
25.77% |
|
PEPTIDOMIMETIC CD40L BINDING |
24.8% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
9.27% |
|
ALZHEIMERS |
8.18% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATION DYNAMICS |
3.56% |
|
ATSTP10 SUCROSE TRANSPORT |
.53% |
|
MEMBRANE TRANSPORT |
.32% |
|
NIPAH VIRUS DECOY PROTEINS |
.12% |